{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:22:32Z","timestamp":1707524552198},"reference-count":6,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,12]]},"DOI":"10.7759\/cureus.24073","type":"journal-article","created":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T14:19:15Z","timestamp":1649773155000},"source":"Crossref","is-referenced-by-count":0,"title":["Transient Ischemic Attack Secondary to Device-Related Thrombus After Left Atrial Appendage Closure"],"prefix":"10.7759","author":[{"given":"Khandakar M","family":"Hussain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashish","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuzhat T","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.M. Anwar","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salah","family":"Aldergash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"5-Year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials","volume":"70","author":"Reddy VY","year":"2017","unstructured":"Reddy VY, Doshi SK, Kar S, et al.. 5-Year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials. J Am Coll Cardiol. 2017, 70:2964-2975. 10.1016\/j.jacc.2017.10.021","journal-title":"J Am Coll Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial","volume":"374","author":"Holmes DR","year":"2009","unstructured":"Holmes DR, Reddy VY, Turi ZG, et al.. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009, 374:534. 10.1016\/S0140-6736(09)61343-X","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.06.041","article-title":"Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: The PREVAIL trial","volume":"219","author":"Belgaid DR","year":"2016","unstructured":"Belgaid DR, Khan Z, Zaidi M, Hobbs A. Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: The PREVAIL trial. Int J Cardiol. 2016, 219:177-179. 10.1016\/j.ijcard.2016.06.041","journal-title":"Int J Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.035090","article-title":"Device-related thrombus after left atrial appendage closure: incidence, predictors, and outcomes","volume":"138","author":"Dukkipati SR","year":"2018","unstructured":"Dukkipati SR, Kar S, Holmes DR, et al.. Device-related thrombus after left atrial appendage closure: incidence, predictors, and outcomes. Circulation. 2018, 138:874-885. 10.1161\/CIRCULATIONAHA.118.035090","journal-title":"Circulation"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.120.010195","article-title":"Device-related thrombus after left atrial appendage closure: data on thrombus characteristics, treatment strategies, and clinical outcomes from the EUROC-DRT-Registry","volume":"14","author":"Sedaghat A","year":"2021","unstructured":"Sedaghat A, Vij V, Al-Kassou B, et al.. Device-related thrombus after left atrial appendage closure: data on thrombus characteristics, treatment strategies, and clinical outcomes from the EUROC-DRT-Registry. Circ Cardiovasc Interv. 2021, 14:e010195. 10.1161\/CIRCINTERVENTIONS.120.010195","journal-title":"Circ Cardiovasc Interv"},{"key":"ref6","article-title":"Antithrombotic therapy and device-related thrombosis following\u00a0endovascular left\u00a0atrial\u00a0appendage closure","volume":"12","author":"Saw J","year":"2019","unstructured":"Saw J, Nielsen-Kudsk JE, Bergmann M, Daniels MJ, Tzikas A, Reisman M, Rana BS. Antithrombotic therapy and device-related thrombosis following\u00a0endovascular left\u00a0atrial\u00a0appendage closure. JACC Cardiovasc Interv. 2019, 12:1067-1076.","journal-title":"JACC Cardiovasc Interv"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/92198-transient-ischemic-attack-secondary-to-device-related-thrombus-after-left-atrial-appendage-closure","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:45:15Z","timestamp":1707507915000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/92198-transient-ischemic-attack-secondary-to-device-related-thrombus-after-left-atrial-appendage-closure"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,12]]},"references-count":6,"URL":"https:\/\/doi.org\/10.7759\/cureus.24073","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,12]]}}}